Provided by Tiger Fintech (Singapore) Pte. Ltd.

Veris Residential

16.31
+0.0000
Post-market: 16.310.00000.00%16:49 EDT
Volume:1.05M
Turnover:17.04M
Market Cap:1.51B
PE:-65.39
High:16.45
Open:16.24
Low:16.03
Close:16.31
Loading ...

Acurx Pharmaceuticals to Present at the Microcap Conference, January 28, 2025 - January 30, 2025

ACCESSWIRE
·
12 Dec 2024

Is it Wise to Retain UDR Stock in Your Portfolio Now?

Zacks
·
11 Dec 2024

Indonesia's PLN Needs Rp4,000 Trillion by 2040 for Energy Transition

Tempo
·
11 Dec 2024

Acurx Updates Phase 3 Readiness for Ibezapolstat in C. difficile Infection Based on Recent FDA and EMA Communications

PR Newswire
·
09 Dec 2024

Should Essex Property Stock be Retained in Your Portfolio Now?

Zacks
·
04 Dec 2024

AvalonBay Stock Gains 19.2% in Six Months: More Room to Run?

Zacks
·
27 Nov 2024

Veris Residential to Present at NAREIT REITweek 2024

TIPRANKS
·
18 Nov 2024

Acurx Sponsored and Participated in the Peggy Lillis Foundation Inaugural CDI Scientific Symposium and Presented Ibezapolstat Ph2b Clinical Data Update

PR Newswire
·
18 Nov 2024

Veris Residential Raises Quarterly Dividend to $0.08 a Share, Payable Jan. 10 to Shareholders of Record Dec. 31

MT Newswires Live
·
14 Nov 2024

Press Release: Veris Residential Declares Quarterly Cash Dividend

Dow Jones
·
14 Nov 2024

Acurx Pharmaceuticals, Inc. Reports Third Quarter 2024 Results and Provides Business Update

PR Newswire
·
13 Nov 2024

Veris Residential Upgraded by Bank of America on Growth Potential

GuruFocus
·
13 Nov 2024

BUZZ-Veris Residential rises as BofA upgrades to 'buy'

Reuters
·
13 Nov 2024

BofA Analyst Doubles Down On Veris Residential Growth, Downgrades Sun Communities - Here's Why

Benzinga
·
13 Nov 2024

Veris Residential Raised to Buy From Neutral by B of A Securities

Dow Jones
·
12 Nov 2024

BofA Securities Upgrades Veris Residential to Buy From Neutral, Price Target is $23

MT Newswires Live
·
12 Nov 2024